e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Treatment strategies, systemic manifestations and biomarkers in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Airway dimensions and pulmonary phenotypes in a heavy smoking population
A. Dijkstra, D. Postma, P. van Ooijen, J. Vonk, P. Zanen, M. Schmidt, H. Groen, F. Mohamed Hoessein (Groningen, Utrecht, Netherlands; Bremen, Germany)
Source:
Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Session:
Treatment strategies, systemic manifestations and biomarkers in airway diseases
Session type:
Thematic Poster Session
Number:
4065
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Dijkstra, D. Postma, P. van Ooijen, J. Vonk, P. Zanen, M. Schmidt, H. Groen, F. Mohamed Hoessein (Groningen, Utrecht, Netherlands; Bremen, Germany). Airway dimensions and pulmonary phenotypes in a heavy smoking population. Eur Respir J 2011; 38: Suppl. 55, 4065
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Effects of exposure to parental smoking on pulmonary function and symptoms in children with asthma
Source: Annual Congress 2011 - Coping and lifestyle in childhood asthma
Year: 2011
Interaction between asthma and smoking increases the risk of adult airway obstruction
Source: Eur Respir J 2015; 45: 635-643
Year: 2015
Comparison of airway T cell phenotypes in COPD and severe asthma: the influence of smoking
Source: Eur Respir J 2005; 26: Suppl. 49, 23s
Year: 2005
CD8+ve airway inflammation in COPD: The impact of smoking status
Source: Annual Congress 2003 - Cigarette smoke: how it does its dirty work
Year: 2003
Airway hyperresponsiveness and its correction during the smoking cessation program
Source: Annual Congress 2007 - Smoking and COPD
Year: 2007
Bronchial hypersensitivity in smoking and non-smoking wood workers: site and nature of airway obstruction
Source: Eur Respir J 2007; 30: Suppl. 51, 337s
Year: 2007
Prevalence of airflow obstruction in smokers and never-smokers in Switzerland
Source: Eur Respir J 2010; 36: 1259-1269
Year: 2010
COPD: causal factors other than active smoking
Source: Annual Congress 2006 - PG3 - Update on occupational and environmental lung disease, including "bring your own cases" for interactive discussion
Year: 2006
Small airway function in smokers without airway obstruction
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
The effect of smoking cessation on methacholine responsiveness in young asthma patients
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
Influence of smoking on airway function and inflammation of asthmatic subjects
Source: Eur Respir J 2004; 24: Suppl. 48, 283s
Year: 2004
Analysis of influence of tobacco in spirometric parameters, pulmonary age SEPAR and ERS: beta angle measurements on intense smokers without COPD or other respiratory diseases
Source: Eur Respir J 2006; 28: Suppl. 50, 467s
Year: 2006
Pulmonary function changes and duration of bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 323s
Year: 2006
Maternal smoking during pregnancy induces airway remodelling in mice offspring
Source: Eur Respir J 2009; 33: 1133-1140
Year: 2009
Smoking status in the patients with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 152s
Year: 2004
Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis
Source: Eur Respir J 2007; 30: 467-471
Year: 2007
The influence of smoking on COPD phenotypes
Source: Eur Respir J 2004; 24: Suppl. 48, 20s
Year: 2004
Patterns of development of airflow limitation in smokers with preserved spirometry and air trapping phenotype in COPDGene
Source: International Congress 2019 – New insights into respiratory function testing
Year: 2019
Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers
Source: Eur Respir J 2005; 26: 835-845
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept